| 25 May 2026 |
Dianabol |
6.1 |
25mg |
24.6mg |
-1.6% |
98.52% |
Lab A |
| 24 May 2026 |
4-Piperidone monohydrate hydrochloride CAS 40064-34-4 |
5.8 |
1g |
1.0g |
+0.5% |
98.45% |
Lab E |
| 24 May 2026 |
NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend |
7.0 |
50mg |
51.1mg |
+2.2% |
95.85% |
Lab A |
| 24 May 2026 |
AICAR |
6.1 |
20mg |
20.8mg |
+3.9% |
96.00% |
Lab D |
| 24 May 2026 |
KPV |
6.8 |
5mg |
4.3mg |
-14.9% |
98.88% |
Lab E |
| 24 May 2026 |
Tirzepatide |
7.3 |
30mg |
35.4mg |
+18.0% |
99.90% |
No Label / Silver Crimp / Orange Cap |
| 24 May 2026 |
KPV Oral |
6.9 |
50mg |
49.2mg |
-1.6% |
96.32% |
Lab G |
| 23 May 2026 |
Tirzepatide |
6.8 |
10mg |
10.9mg |
+9.0% |
99.90% |
No Label / Silver Crimp / Green Cap |
| 23 May 2026 |
Retatrutide |
7.8 |
20mg |
18.9mg |
-5.5% |
99.90% |
No Label / Silver Crimp / Blue Cap |
| 23 May 2026 |
Oxytocin Acetate |
6.8 |
15mg |
18.3mg |
+22.0% |
96.57% |
Lab C |
| 23 May 2026 |
Relaxation PM (GABA 100mg+Melatonin 1mg+Arginine 100mg+Glutamine 25mg) |
5.7 |
300mg/ml |
259.2mg/ml |
-13.6% |
98.07% |
Lab E |
| 23 May 2026 |
Tirzepatide |
8.0 |
40mg |
39.3mg |
-1.8% |
99.90% |
No Label / Silver Crimp / Clear Blue Cap |
| 23 May 2026 |
L-Carnitine 500mg |
6.7 |
250mg/ml |
293.4mg/ml |
+17.3% |
97.73% |
Lab A |
| 21 May 2026 |
Tirzepatide |
2.0 |
60mg |
⚠️ Sample does not contain Tirzepatide ? |
n/a |
60-T-7-5 |
Public |
| 21 May 2026 |
AICAR |
4.6 |
2mg |
2.1mg |
+5.3% |
98.24% |
Lab E |
| 21 May 2026 |
Blend 375 (Tren E 125mg+Mast E 125mg+Test E 125mg) |
6.8 |
200mg/ml |
204.0mg/ml |
+2.0% |
99.16% |
Lab C |
| 21 May 2026 |
BPC157 5mg + TB500 5mg Blend |
5.1 |
10mg |
11.7mg |
+16.9% |
97.69% |
Lab B |
| 21 May 2026 |
Tirzepatide |
4.7 |
30mg |
17.8mg |
-40.7% |
99.90% |
No Label / Silver Crimp / Orange Cap |
| 21 May 2026 |
Tirzepatide |
9.5 |
20mg |
21.3mg |
+6.5% |
99.90% |
No Label / Copper Crimp / Clear Cap |
| 21 May 2026 |
AHK-CU |
8.3 |
5mg |
5.2mg |
+4.9% |
96.57% |
Lab C |
| 21 May 2026 |
Blend 300 (TRA/Mast P/Test P) |
5.8 |
250mg/ml |
217.8mg/ml |
-12.9% |
98.69% |
Lab E |
| 21 May 2026 |
Blend 375 (Tren E 125mg+Mast E 125mg+Test E 125mg) |
4.7 |
200mg/ml |
199.0mg/ml |
-0.5% |
98.20% |
Lab E |
| 21 May 2026 |
KPV Oral |
5.7 |
50mg |
59.1mg |
+18.1% |
96.82% |
Lab C |
| 21 May 2026 |
L-Carnitine 500mg |
8.3 |
100mg/ml |
104.1mg/ml |
+4.1% |
96.07% |
Lab A |
| 21 May 2026 |
SHRED (L-Carnitine 200mg+B12+B6+Inositol+Methionine+Choline) |
5.1 |
100mg/ml |
87.7mg/ml |
-12.3% |
97.77% |
Lab B |
| 21 May 2026 |
Tesamorelin 11mg + Ipamorelin 6mg Blend |
6.9 |
50mg |
59.6mg |
+19.2% |
96.36% |
Lab F |
| 20 May 2026 |
Arimidex (Anastrozole) |
7.8 |
25mg |
27.3mg |
+9.0% |
95.57% |
Lab D |
| 20 May 2026 |
Vilon |
5.2 |
2mg |
2.2mg |
+9.2% |
97.81% |
Lab F |
| 19 May 2026 |
NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend |
5.2 |
20mg |
17.4mg |
-12.8% |
98.16% |
Lab E |
| 17 May 2026 |
BPC157 5mg + TB500 5mg Blend |
5.9 |
10mg |
12.0mg |
+19.9% |
99.54% |
Lab A |
| 17 May 2026 |
HGH Fragment 176-191 |
7.0 |
50mg |
59.8mg |
+19.6% |
95.63% |
Lab E |
| 26 Jan 2026 |
Tadalafil Raw |
6.6 |
5g |
5.2g |
+3.3% |
96.18% |
Lab C |
| 9 Jan 2026 |
Phenylacetic acid CAS 103-82-2 |
5.4 |
500g |
593.1g |
+18.6% |
99.23% |
Lab F |
| 9 Jan 2026 |
Tadalafil Raw |
7.1 |
10g |
9.7g |
-3.4% |
96.99% |
Lab C |
| 7 Jan 2026 |
Alprostadil |
4.9 |
30mg |
34.2mg |
+13.9% |
98.14% |
Lab D |
| 7 Jan 2026 |
Andarine S4 |
4.7 |
50mg |
49.9mg |
-0.1% |
99.56% |
Lab E |
| 7 Jan 2026 |
Blend 375 (Tren E 125mg+Mast E 125mg+Test E 125mg) |
5.9 |
100mg/ml |
91.5mg/ml |
-8.5% |
95.36% |
Lab A |
| 7 Jan 2026 |
BPC157 5mg + TB500 5mg Blend |
7.3 |
5mg |
5.6mg |
+11.5% |
99.55% |
Lab F |
| 7 Jan 2026 |
L-Carnitine 500mg |
5.8 |
200mg/ml |
238.4mg/ml |
+19.2% |
95.63% |
Lab E |
| 7 Jan 2026 |
Tesamorelin 11mg + Ipamorelin 6mg Blend |
7.3 |
5mg |
5.0mg |
-1.0% |
99.27% |
Lab A |
| 6 Jan 2026 |
AHK-CU |
7.8 |
5mg |
5.2mg |
+3.1% |
95.58% |
Lab C |
| 6 Jan 2026 |
CJC-1295 w/o DAC 5mg + IPA 5mg Blend |
6.0 |
2mg |
2.0mg |
-1.9% |
99.93% |
Lab E |
| 6 Jan 2026 |
Humanin |
5.4 |
20mg |
20.9mg |
+4.4% |
99.80% |
Lab F |
| 6 Jan 2026 |
Relaxation PM (GABA 100mg+Melatonin 1mg+Arginine 100mg+Glutamine 25mg) |
6.7 |
100mg/ml |
91.2mg/ml |
-8.8% |
98.63% |
Lab G |
| 29 Dec 2025 |
Pancragen |
7.5 |
5mg |
5.8mg |
+16.1% |
97.93% |
Lab F |
| 29 Dec 2025 |
Pinealon |
8.4 |
2mg |
2.0mg |
+2.4% |
98.90% |
Lab B |
| 12 Dec 2025 |
NandroMix 300 |
4.0 |
250mg/ml |
279.9mg/ml |
+12.0% |
98.90% |
Lab C |
| 12 Dec 2025 |
Winstrol (Stanozolol) |
5.9 |
10mg |
10.2mg |
+1.6% |
99.06% |
Lab C |
| 5 Dec 2025 |
Relaxation PM (GABA 100mg+Melatonin 1mg+Arginine 100mg+Glutamine 25mg) |
7.1 |
100mg/ml |
99.3mg/ml |
-0.7% |
99.49% |
Lab C |
| 5 Dec 2025 |
Vilon |
6.5 |
50mg |
44.4mg |
-11.1% |
96.01% |
Lab D |
| 23 Nov 2025 |
Andarine S4 |
8.2 |
10mg |
12.3mg |
+23.0% |
97.83% |
Lab E |
| 23 Nov 2025 |
KPV |
6.7 |
30mg |
33.8mg |
+12.7% |
96.73% |
Lab G |
| 23 Nov 2025 |
Tesamorelin 11mg + Ipamorelin 6mg Blend |
6.7 |
20mg |
21.7mg |
+8.7% |
95.75% |
Lab D |
| 17 Nov 2025 |
AICAR |
4.4 |
15mg |
15.1mg |
+0.5% |
98.47% |
Lab E |
| 14 Nov 2025 |
Alprostadil |
5.3 |
5mg |
5.6mg |
+12.5% |
98.37% |
Lab B |
| 14 Nov 2025 |
Pancragen |
10.0 |
50mg |
48.5mg |
-3.1% |
99.95% |
Lab B |
| 5 Nov 2025 |
AHK-CU |
7.6 |
50mg |
51.2mg |
+2.5% |
99.99% |
Lab F |
| 5 Nov 2025 |
KPV Oral |
4.1 |
25mg |
30.4mg |
+21.6% |
99.33% |
Lab C |
| 5 Nov 2025 |
Pancragen |
7.0 |
50mg |
45.5mg |
-9.0% |
96.89% |
Lab C |
| 5 Nov 2025 |
Pancragen |
9.8 |
10mg |
9.8mg |
-2.2% |
97.99% |
Lab B |
| 5 Nov 2025 |
Phenylacetic acid CAS 103-82-2 |
7.9 |
500g |
559.9g |
+12.0% |
99.65% |
Lab A |
| 4 Nov 2025 |
Andarine S4 |
7.7 |
100mg |
93.0mg |
-7.0% |
96.68% |
Lab F |
| 4 Nov 2025 |
KPV Oral |
5.1 |
20mg |
19.4mg |
-3.2% |
99.76% |
Lab F |
| 4 Nov 2025 |
L-Carnitine 500mg |
7.3 |
300mg/ml |
333.9mg/ml |
+11.3% |
98.47% |
Lab D |
| 4 Nov 2025 |
Retatrutide 30mg Pen Kit |
8.7 |
20mg |
20.0mg |
-0.1% |
97.40% |
Lab D |
| 17 Oct 2025 |
AHK-CU |
7.8 |
2mg |
2.4mg |
+17.7% |
98.08% |
Lab A |
| 17 Oct 2025 |
Alprostadil |
4.0 |
30mg |
29.5mg |
-1.7% |
96.68% |
Lab D |
| 17 Oct 2025 |
CJC-1295 With DAC |
6.6 |
10mg |
12.5mg |
+24.6% |
96.09% |
Lab C |
| 17 Oct 2025 |
Humanin |
6.6 |
15mg |
14.0mg |
-6.9% |
97.82% |
Lab C |
| 17 Oct 2025 |
KPV |
6.9 |
50mg |
47.8mg |
-4.5% |
95.22% |
Lab D |
| 17 Oct 2025 |
Vilon |
5.4 |
30mg |
34.8mg |
+16.0% |
98.13% |
Lab F |
| 9 Oct 2025 |
Alprostadil |
5.6 |
2mg |
2.1mg |
+7.2% |
97.49% |
Lab F |
| 9 Oct 2025 |
Blend 375 (Tren E 125mg+Mast E 125mg+Test E 125mg) |
5.4 |
100mg/ml |
93.2mg/ml |
-6.8% |
97.12% |
Lab D |
| 9 Oct 2025 |
HGH Fragment 176-191 |
7.4 |
50mg |
48.3mg |
-3.5% |
98.97% |
Lab A |
| 9 Oct 2025 |
Humanin |
7.4 |
15mg |
15.0mg |
-0.0% |
95.34% |
Lab F |
| 9 Oct 2025 |
Tadalafil Raw |
5.5 |
100g |
101.8g |
+1.8% |
95.73% |
Lab A |
| 9 Oct 2025 |
Tadalafil Raw |
6.8 |
10g |
12.2g |
+22.4% |
95.68% |
Lab D |
| 3 Oct 2025 |
4-Piperidone monohydrate hydrochloride CAS 40064-34-4 |
8.5 |
100g |
113.6g |
+13.6% |
98.50% |
Lab C |
| 3 Oct 2025 |
Blend 300 (TRA/Mast P/Test P) |
6.0 |
250mg/ml |
235.4mg/ml |
-5.9% |
98.54% |
Lab F |
| 3 Oct 2025 |
SHRED (L-Carnitine 200mg+B12+B6+Inositol+Methionine+Choline) |
5.6 |
100mg/ml |
102.0mg/ml |
+2.0% |
97.24% |
Lab D |